The assay displays a promising tool for saving precious serum samples when evaluating IgA and IgG antibodies in seroepidemiological studies and, furthermore, provides a cost-optimized method for NPC screening within NPC-endemic areas. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.